Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Series A Preferred Stock [Member]	Series A-2 Preferred Stock [Member]	Series B Preferred Stock [Member]	Common Stock	Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Shares at Feb. 29, 2016	874,257	0	659	1,851,201
Beginning Balance, Amount at Feb. 29, 2016	$ 87	$ 0	$ 0	$ 185	$ 21,607,259	$ (23,377,328)	$ (1,769,797)
Issuance of common stock, preferred stock and warrants for cash, net of offering costs, Shares		48,300		1,065,750
Issuance of common stock, preferred stock and warrants for cash, net of offering costs, Amount		$ 5		$ 107	962,550		962,662
Issuance of common stock and warrants to convert accounts payable, Shares				32,500
Issuance of common stock and warrants to convert accounts payable, Amount				$ 3	212,275		212,278
Issuance of common stock and warrants to convert notes payable, Shares		16,000		440,500
Issuance of common stock and warrants to convert notes payable, Amount		$ 2		$ 44	1,566,755		1,566,801
Beneficial conversion feature of Series B Preferred Stock					708,303		708,303
Deemed dividend to Series B Preferred Stock					(708,303)		(708,303)
Accrued dividends on Series B Preferred Stock					(227,163)		(227,163)
Series B PIK Dividend, Shares			35
Series B PIK Dividend, Amount			$ 0		191,941		191,941
Reclassification between warrant liability and additional paid-in-capital							0
Issuance of common stock, preferred stock and warrants in exchange for cancellation of Series B preferred stock and Series A Warrants, Shares		6,241	(481)	1,292,991
Issuance of common stock, preferred stock and warrants in exchange for cancellation of Series B preferred stock and Series A Warrants, Amount		$ 0	$ 0	$ 129	747,486		747,615
Deemed dividend to Series B Preferred Stock holders for exchange of warrants					(2,340,552)		(2,340,552)
Issuance of warrants in connection with OID Notes amendment					44,095		44,095
Issuance of warrants in connection with convertible note					117,632		117,632
Share-based compensation, Shares				25,000
Share-based compensation, Amount				$ 3	640,862		640,865
Net Loss						(2,941,557)	(2,941,557)
Ending Balance, Shares at Feb. 28, 2017	874,257	70,541	213	4,707,942
Ending Balance, Amount at Feb. 28, 2017	$ 87	$ 7	$ 0	$ 471	23,523,140	(26,318,885)	(2,795,180)
Issuance of common stock, preferred stock and warrants for cash, net of offering costs, Shares		229,363		783,898
Issuance of common stock, preferred stock and warrants for cash, net of offering costs, Amount		$ 23		$ 78	2,308,081		2,308,182
Issuance of common stock to convert Series A preferred stock, Shares	(874,257)			58,283
Issuance of common stock to convert Series A preferred stock, Amount	$ (87)			$ 6	81
Issuance of common stock to convert Series A-2 preferred stock, Shares		(20,000)		200,000
Issuance of common stock to convert Series A-2 preferred stock, Amount		$ (2)		$ 20	(18)
Issuance common stock to convert accrued expenses, Shares				27,260
Issuance common stock to convert accrued expenses, Amount				$ 3	23,654		23,657
Accrued dividends on Series B Preferred Stock					(97,968)		(97,968)
Series B PIK Dividend, Shares			13
Series B PIK Dividend, Amount					71,787		71,787
Modification on warrant exercise price					31,139		31,139
Deemed dividend related to warrants exercise price modification					(31,139)		(31,139)
Reclassification between warrant liability and additional paid-in-capital					1,471,262		1,471,262
Issuance of warrants in connection with OID Notes amendment							0
Share-based compensation, Shares				100,000
Share-based compensation, Amount				$ 10	650,332		650,342
Net Loss						(3,181,024)	(3,181,024)
Ending Balance, Shares at Feb. 28, 2018	0	279,904	226	5,877,383
Ending Balance, Amount at Feb. 28, 2018	$ 0	$ 28	$ 0	$ 588	$ 27,950,351	$ (29,499,909)	$ (1,548,942)

MetaStat, Inc. 10-K